Drug access to the CNS is hindered by the presence of the blood-brain barrier (BBB), and the intranasal route has risen as a non-invasive route to transport drugs directly from nose-to-brain avoiding the BBB. In addition, nanoparticles (NPs) have been described as efficient shuttles for direct nose-to-brain delivery of drugs. Nevertheless, there are few studies describing NP nose-to-brain transport. Thus, the aim of this work was (i) to develop, characterize and validate in vitro olfactory cell monolayers and (ii) to study the transport of polymeric- and lipid-based NPs across these monolayers in order to estimate NP access into the brain using cell penetrating peptide (CPPs) moieties: Tat and Penetratin (Pen). All tested poly(d,l-lactide-co-glycolide) (PLGA) and nanostructured lipid carrier (NLC) formulations were stable in transport buffer and biocompatible with the olfactory mucosa cells. Nevertheless, 0.7% of PLGA NPs was able to cross the olfactory cell monolayers, whereas 8% and 22% of NLC and chitosan-coated NLC (CS-NLC) were transported across them, respectively. Moreover, the incorporation of CPPs to NLC surface significantly increased their transport, reaching 46% of transported NPs. We conclude that CPP-CS-NLC represent a promising brain shuttle via nose-to-brain for drug delivery.

Biomedical Research Networking Center in Bioengineering Biomaterials and Nanomedicine Vitoria Gasteiz 01006 Spain

Integrated Center for Cell Therapy and Regenerative Medicine International Clinical Research Center St Anne's University Hospital Brno Pekařská 53 Brno 656 91 Czech Republic

NanoBioCel Group Laboratory of Pharmaceutics School of Pharmacy University of the Basque Country Vitoria Gasteiz 01006 Spain

Université Catholique de Louvain Louvain Drug Research Institute Advanced Drug Delivery and Biomaterials Brussels Belgium

References provided by Crossref.org